Axogen, Inc. Non Peo Neo Avg Total Comp Amt
Axogen, Inc. (AXGN) reported Non Peo Neo Avg Total Comp Amt of $1.96 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-29.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-29
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $1.96M DEF 14A · filed 2026-04-29 |
| 2024-12-31 | $2.23M DEF 14A · filed 2026-04-29 |
| 2023-12-31 | $1.95M DEF 14A · filed 2026-04-29 |
| 2022-12-31 | $1.52M DEF 14A · filed 2026-04-29 |
| 2021-12-31 | $1.82M DEF 14A · filed 2026-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |